EntryPoint Capital’s Core Scientific CORZ Stock Holding History

EntryPoint Capital’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23,214	Closed	-$326K	–	721
2024 Q4	$326K	Buy	+23,214	New	+$343K	0.14%	327

Other funds holding CORZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return

OWP

ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

JCM

JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HPM

Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return

EntryPoint Capital's CORZ Position: Q1 2025 in Review

EntryPoint Capital sold out of Core Scientific (CORZ) in Q1 2025, closing a stake of 23,214 shares — an estimated $326K sold.

EntryPoint Capital first reported a position in CORZ in Q4 2024 and held it in 1 quarter. The position peaked at $326K in Q4 2024. 336 funds tracked by Wall St. Rank hold CORZ as of Q1 2025.

EntryPoint Capital reported no remaining Core Scientific position as of Q1 2025 after selling out during the quarter.
EntryPoint Capital sold 23,214 Core Scientific shares in Q1 2025, an estimated $326K.
EntryPoint Capital first reported a position in Core Scientific in Q4 2024 and held it in 1 quarter.
EntryPoint Capital's Core Scientific position peaked at $326K in Q4 2024.
336 funds tracked by Wall St. Rank held Core Scientific as of Q1 2025.

Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.